Actively Recruiting
MRI Radiomics and Clinical Model to Predict Response to Neoadjuvant Therapy in Head and Neck Squamous Cell Carcinoma
Led by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Updated on 2026-08-31
750
Participants Needed
1
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Head and neck squamous cell carcinoma is a common malignant tumor worldwide. Neoadjuvant therapy, which includes chemotherapy and immunotherapy, is recommended for patients with locally advanced disease. The response to this therapy varies, and about 37% of patients achieve pathological complete remission, which is linked to better outcomes. Accurately predicting which patients will respond well to neoadjuvant therapy is important to help tailor individual treatment plans. This trial focuses on improving prediction methods using MRI imaging combined with clinical factors. The study evaluates a diagnostic approach that uses MRI-based radiomics features along with clinical risk factors to predict the likelihood of pathological complete remission after neoadjuvant chemoimmunotherapy in patients with head and neck squamous cell carcinoma. Participants receive two or three courses of neoadjuvant chemotherapy combined with PD-1 inhibitor immunotherapy, followed by radical surgical removal of the tumor. MRI scans are done within 30 days before starting therapy to provide imaging data for the radiomics model. Participants will be monitored through MRI imaging and clinical data collection before and after neoadjuvant therapy and surgery. Researchers will analyze the predictive accuracy of the MRI-based radiomics-clinical model using measures such as the area under the receiver operating characteristic curves AUROC. The study aims to improve diagnostic imaging remission assessment to support clinical decisions. The total study period extends up to December 2028, with the primary outcome measured between January 2021 and February 2023.
CONDITIONS
Brief Title
Application of MRI Radiomics Features in Neoadjuvant Therapy of Head and Neck Squamous Cell Carcinoma
Research Team
L
Lin
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here